A team led by researchers at UCLA and the University of Pennsylvania has produced a first-of-its kind catalog of gene-isoform variation in the developing human brain. This novel dataset provides crucial insights into the ...
May 23, 2024
0
34
For the first time, researchers led by Professor Dr. Petra Ritter's team have succeeded in explaining the propagation of traveling waves of activity in the human brain using a computer simulation. Previous studies indicate ...
May 16, 2024
0
79
Two studies from Oxford Population Health have discovered proteins in the blood that could warn people of cancer more than seven years before it is diagnosed.
May 15, 2024
0
89
Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain ...
Jun 5, 2024
0
35
Most people use Google Street View to find their way. Dr. Quynh Nguyen, an epidemiologist and statistician at the University of Maryland School of Public Health, uses it to locate spots where your journey might abruptly end. ...
Jun 8, 2024
0
34
Aerobic training is known to regulate blood pressure more effectively when practiced in the evening than in the morning. Researchers who conducted a study of elderly patients at the University of São Paulo's School of Physical ...
May 17, 2024
0
23
In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid—an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19—proved safe as an extended-duration ...
Jun 7, 2024
0
71
In 2018, a New York surgeon-scientist and his team demonstrated in a proof-of-concept study that a minimally invasive procedure could effectively treat one of the world's most common conditions requiring neurosurgical intervention.
Imagine a future where the smell of menthol could alleviate some of the worst symptoms of Alzheimer's disease. This might sound like science fiction, but innovative new research is making it a potential reality.
Jun 12, 2024
0
76
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular ...
May 25, 2024
0
1
